[144] Walker & Dunlop, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice by Walker & Dunlop, Inc. (WD) proposing the sale of 5,336 common shares with an aggregate market value of $459,963.20. The shares represent a small portion of the company's outstanding common stock (34,069,118 shares) and the proposed approximate sale date is 08/29/2025 on the NYSE. The shares to be sold were acquired through restricted stock vesting as compensation on 03/15/2024 (950 shares), 02/15/2025 (2,010 shares), 03/14/2025 (6 shares) and 03/15/2025 (2,370 shares). The filer states there were no securities sold in the past three months and includes the standard representation that the person does not possess undisclosed material adverse information.

Positive

• Shares were acquired as compensation through restricted stock vesting, with acquisition dates and amounts disclosed explicitly
• No securities sold in the past three months, per the filing

Negative

• None.

Insights

Securities Analyst

TL;DR: Small planned sale of insider-held restricted shares; not materially dilutive given outstanding share count.

The filing shows a proposed sale of 5,336 common shares valued at $459,963.20, acquired through restricted stock vesting across 2024–2025 and scheduled for sale on 08/29/2025 via NYSE. Relative to 34,069,118 shares outstanding, the lot is immaterial from a dilution perspective. The notice follows Rule 144 disclosure requirements and reports no related sales in the prior three months. For investors, this is a routine insider liquidity event rather than a company operational disclosure.

Corporate Governance Expert

TL;DR: Routine compliance filing; indicates issuances were compensation-based restricted stock vesting.

The document documents that the securities proposed for sale were acquired as compensation via restricted stock vesting on specific dates in 2024 and 2025. The filer affirms lack of undisclosed material information and attaches the mandatory caution about false statements. There are no disclosures of other recent sales or related-party transactions in the past three months. From a governance standpoint, the filing reflects standard disclosure and insider exercising of vested compensation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5336	459963.20	34069118	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Restricted Stock Vesting	Issuer			950	03/15/2024	Compensation
Common	02/15/2025	Restricted Stock Vesting	Issuer			2010	02/15/2025	Compensation
Common	03/14/2025	Restricted Stock Vesting	Issuer			6	03/14/2025	Compensation
Common	03/15/2025	Restricted Stock Vesting	Issuer			2370	03/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Walker & Dunlop (WD) Form 144 disclose?

The filing discloses a proposed sale of 5,336 common shares with an aggregate market value of $459,963.20, planned for 08/29/2025 on the NYSE.

How were the WD shares being sold acquired?

All listed shares were acquired through restricted stock vesting as compensation on dates in 2024 and 2025 (03/15/2024; 02/15/2025; 03/14/2025; 03/15/2025).

How many WD shares are outstanding and how material is the proposed sale?

The filing reports 34,069,118 shares outstanding; the proposed sale of 5,336 shares is immaterial relative to the outstanding share count.

Did the filer report other sales of WD securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

On which exchange will the WD shares be sold?

The proposed sale is listed as occurring on the NYSE.